| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |